{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:28:14Z","timestamp":1781072894474,"version":"3.54.1"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1955,5]]},"DOI":"10.1212\/wnl.5.5.319","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T14:09:02Z","timestamp":1336918142000},"page":"319-319","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":33,"title":["Frenquel, a Blocking Agent Against Experimental LSD\u201025 and Mescaline Psychosis"],"prefix":"10.1212","volume":"5","author":[{"given":"Howard D.","family":"Fabing","sequence":"first","affiliation":[{"name":"neurology service, Christ Haspital, Cincinnati, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.5.5.319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T17:11:50Z","timestamp":1711645910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.5.5.319"}},"subtitle":["Preliminary Note on its Clinical Application"],"short-title":[],"issued":{"date-parts":[[1955,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1955,5]]}},"alternative-id":["10.1212\/WNL.5.5.319"],"URL":"https:\/\/doi.org\/10.1212\/wnl.5.5.319","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1955,5]]}}}